AZD4547: Phase Ib/IIa started

Cancer Research UK (London, U.K) began a dose-finding, U.K. Phase Ib/IIa trial to evaluate AstraZeneca's AZD4547 plus cisplatin and capecitabine. The Phase

Read the full 237 word article

User Sign In